Core Laboratories Stock Executives

CLB
 Stock
  

USD 13.33  0.58  4.17%   

Core Laboratories employes about 3.6 K people. The company is managed by 33 executives with total tenure of roughly 146 years, averaging almost 4.0 years of service per executive having 109.09 employees per reported executive. Analysis of Core Laboratories management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Core Laboratories future performance.
Continue to Trending Equities.
  
  Lawrence Bruno  Chairman
Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
  David Demshur  Chairman
Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer
  Christopher Hill  President
Chief Financial Officer, Senior Vice President

Core Laboratories Management Team Effectiveness

Core Laboratories has Return on Asset of 3.53 % which means that on every $100 spent on asset, it made $3.53 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.55 %, implying that it generated $5.55 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Core Laboratories Workforce Comparison

Core Laboratories NV is number one stock in number of employees category among related companies. The total workforce of Oil & Gas Equipment & Services industry is currently estimated at about 7,200. Core Laboratories totals roughly 3,600 in number of employees claiming about 50% of all equities under Oil & Gas Equipment & Services industry.

Core Laboratories Profit Margins

The company has Net Profit Margin of 1.82 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 10.64 %, which entails that for every 100 dollars of revenue, it generated 0.11 of operating income.

Core Laboratories Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Core Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Core Laboratories Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Core Laboratories Price Series Division is a division of Core Laboratories price series and its benchmark/peer.
.

Core Laboratories Notable Stakeholders

A Core Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Core Laboratories often face trade-offs trying to please all of them. Core Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Core Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lawrence Bruno - Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating OfficerProfile
David Demshur - Independent Chairman of the Board of Supervisory Directors and Chief Executive OfficerProfile
Tahera Khan - Vice President Human ResourcesProfile
Gwendolyn Schreffler - Senior Vice President, Corporate Development and Investor RelationsProfile
Michael Flecker - Vice President Production EnhancementProfile
Christopher Hill - Chief Financial Officer, Senior Vice PresidentProfile
Alastair Crombie - Vice President Reservoir DescriptionProfile
Mark Elvig - Senior Vice President, Secretary, and General CounselProfile
David Hume - Vice President Reservoir DescriptionProfile
Kevin Daniels - Vice President, Chief Accounting OfficerProfile
James Gresham - Senior Vice President Business DevelopmentProfile
Peter Boks - Vice President Reservoir DescriptionProfile
Jeffrey West - Vice President Production EnhancementProfile
Dumas - Vice President Business DevelopmentProfile
Monty Davis - COO and Sr. VPProfile
Charles Dunlap - Independent Member of the Board of Supervisory DirectorsProfile
Richard Bergmark - CFO, Executive VP and Supervisory DirectorProfile
Michael Kearney - Independent Supervisory DirectorProfile
Margaret Kempen - Independent Member of the Board of Supervisory DirectorsProfile
Lucia Geuns - Independent Member of the Board of Supervisory DirectorsProfile
Jan Sodderland - Independent Member of the Board of Supervisory DirectorsProfile
Chris Hill - Chief Accounting Officer and VPProfile
Monique Eeuwijk - Non-Executive Independent Member of the Supervisory BoardProfile
D Ogren - Member of the Supervisory BoardProfile
Harvey Klingensmith - Non-Executive Independent Member of the Supervisory BoardProfile
Michael Straughen - Non-Executive Independent Member of the Supervisory BoardProfile
John Ogren - Member of the Supervisory BoardProfile
J Dumas - Vice President Business DevelopmentProfile
Martha Carnes - Presiding Non-Executive Lead Independent Member of the Supervisory BoardProfile
Kwaku Temeng - Non-Executive Independent Member of the Supervisory BoardProfile
Gregory Barnett - Non-Executive Independent Member of the Supervisory BoardProfile
Mark Tattoli - Senior Vice President General Counsel, SecretaryProfile
Gwendolyn Gresham - Senior Vice President Corporate Development and Investor RelationsProfile

About Core Laboratories Management Performance

The success or failure of an entity such as Core Laboratories often depends on how effective the management is. Core Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Core Laboratories management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Core Laboratories management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States.
The data published in Core Laboratories' official financial statements usually reflect Core Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Core Laboratories. For example, before you start analyzing numbers published by Core Laboratories accountants, it's critical to develop an understanding of what Core Laboratories' liquidity, profitability, and earnings quality are in the context of the Energy space in which it operates.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Core Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Laboratories NV. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management to manipulate its earnings.

Core Laboratories Workforce Analysis

Traditionally, organizations such as Core Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Core Laboratories within its industry.

Core Laboratories Manpower Efficiency

Return on Core Laboratories Manpower

Revenue Per Employee133.1 K
Revenue Per Executive14.5 M
Net Income Per Employee2.4 K
Net Income Per Executive264.8 K
Working Capital Per Employee32.7 K
Working Capital Per Executive3.6 M
Continue to Trending Equities. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.